Month: April 2021

SPONSORED CONTENT by Ross Halsne

It’s becoming increasingly difficult for Covered Entities (CEs) to effectively manage their 340B pharmacy programs.  Often times understaffed relative to the task of handling the myriad of challenges that come with managing a 340B program, they face a seemingly constant barrage of maneuvering and attacks aimed at reducing their 340B benefit.  In response, many Covered Entities are evaluating new strategies to strengthen or reinvigorate their program. If your Covered Entity is taking a fresh

SPONSORED CONTENT

Please join us for a conversation about why protecting the 340B program is critical to ensuring patient access to health care as well as a legislative update on what’s happening with manufacturers and contract pharmacies, discriminatory reimbursement, and state carve outs.

Learn how Covered Entities can advocate on behalf of themselves and their patients and the tools necessary to support your advocacy efforts. Our